Monitoring concentration and lipid signature of plasma extracellular vesicles from HR+ metastatic breast cancer patients under CDK4/6 inhibitors treatment

MLA

Mathilde Richard, et al. “Monitoring Concentration and Lipid Signature of Plasma Extracellular Vesicles from HR+ Metastatic Breast Cancer Patients under CDK4/6 Inhibitors Treatment.” Journal of Extracellular Biology, vol. 3, no. 12, Dec. 2024. EBSCOhost, https://doi.org/10.1002/jex2.70013.

APA

Mathilde Richard, Rosalie Moreau, Mikaël Croyal, Laurent Mathiot, Jean‐Sébastien Frénel, Mario Campone, Aurélien Dupont, Julie Gavard, Gwennan André‐Grégoire, & Laëtitia Guével. (2024). Monitoring concentration and lipid signature of plasma extracellular vesicles from HR+ metastatic breast cancer patients under CDK4/6 inhibitors treatment. Journal of Extracellular Biology, 3(12). https://doi.org/10.1002/jex2.70013

Chicago

Mathilde Richard, Rosalie Moreau, Mikaël Croyal, Laurent Mathiot, Jean‐Sébastien Frénel, Mario Campone, Aurélien Dupont, Julie Gavard, Gwennan André‐Grégoire, and Laëtitia Guével. 2024. “Monitoring Concentration and Lipid Signature of Plasma Extracellular Vesicles from HR+ Metastatic Breast Cancer Patients under CDK4/6 Inhibitors Treatment.” Journal of Extracellular Biology 3 (12). doi:10.1002/jex2.70013.